Health lender citigroup buys Wachovia; Study says hormone replacement may be safe;

> The market turmoil has wreaked yet another change in the financial landscape for healthcare financial managers with the acquisition of banking company Wachovia by healthcare lending colossus Citigroup. FierceHealthFinance

> A new Danish study suggests that hormone replacement therapy might not put women at increased risk of heart disease, despite longstanding fears to this effect. FiercePharma

> Are open source electronic medical records a threat to commercial software vendors? I don't think so, but one of the country's leading health IT trade groups seems convinced that they are. FierceHealthIT

> A federal judge awarded Johnson & Johnson's cardiac device unit $1.2 billion in a longstanding battle between J&J, Boston Scientific and Medtronic over a stent device. FiercePharma

And Finally... It's a full-sized house for $1.75...no, not $1.75 million, one dollar and seventy-five cents. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.